BPC-157 Arginate vs TB-500 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 Arginate is the arginine salt form of BPC-157, identical in the GEPPPGKPADDAGLV peptide sequence but with improved water solubility, aqueous stability, and oral bioavailability. The arginate counterion buffers GI microenvironmental pH, reducing acid-catalyzed peptide degr...
Calculate BPC-157 Arginate dose →TB-500 is a synthetic fragment of Thymosin Beta-4, concentrated naturally in platelets and wound fluid. It promotes cell migration, angiogenesis, and systemic tissue repair via actin polymerization. Half-life of approximately 5 days enables twice-weekly dosing. WADA prohibited un...
Calculate TB-500 dose →| Parameter | BPC-157 Arginate | TB-500 |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | 4–6 hours | ~5 days |
| Typical Dose | 250–500 µg | 2.5–5 mg |
| Frequency | Once or twice daily | 2–3× per week |
| Route | Oral / Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.